Larimar Therapeutics, Inc. (LRMR)
4.79
+0.11
(+2.35%)
USD |
NASDAQ |
Apr 02, 16:00
4.775
-0.02
(-0.31%)
After-Hours: 20:00
Larimar Therapeutics Shareholders Equity (Quarterly) : 78.08M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vir Biotechnology, Inc. | 765.28M |
| Gossamer Bio, Inc. | -122.76M |
| ImmunityBio, Inc. | -500.47M |
| BioRestorative Therapies, Inc. | 0.3567M |
| Iovance Biotherapeutics, Inc. | 698.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 146.46M |
| Total Liabilities (Quarterly) | 68.37M |
| Debt to Equity Ratio | 0.0521 |
| Current Ratio | 2.192 |
| Net Debt Paydown Yield | 0.08% |